and risk related fundamentals. It is very tough to do a DT, since aiming for a 3-5% gain could end up with 30-50% loss.
In general 80% of p3 trial are failed which means for a development company could lose 50% and more. So the selecting stock is very critical, which makes even harder for a DT.
Biotech is the most volatile sector. You need to understand the
本帖于 2015-05-01 18:53:59 时间, 由普通用户 三丝 编辑